logo
Ludwig N. Hantson's profile picture

Ludwig N. Hantson

Also Known As Ludwig Norbert Michel Hantson

CEO of Alexion Pharmaceuticals

Education

  • PhD - Motor Rehabilitation and Physical Therapy - University of Louvain in Belgium

Overview

Ludwig Norbert Michel Hantson CEO of Alexion Pharmaceuticals, Inc.(ALXN) since March 2017.

Hantson was corporate vice president and president, international of Baxter from May 2010, before becoming CEO of Baxalta from July 2015, when Baxalta was spun off by its parent company, Baxter International until the finalization of Baxalta's acquisition a year later (completed June 2016) by Shire.

It was reported in January 2016 that Hantson's exit package, in cash and Shire stock, could be more than $30 million.

In March 2017, Alexion Pharmaceuticals named Hantson as its CEO.

In September 2017, Hantson relocated Alexion Pharmaceuticals's headquarters to Massachusetts

Early Life

Ludwig Norbert Michel Hantson born August 1962 received a PhD in Motor Rehabilitation and Physical Therapy from the University of Louvain in Belgium.                                 

Career

  • Alexion Pharmaceuticals - CEO

Reference

Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250131